fbpx
November 5, 2025

Estaderma – 718714 – 11/03/2025

Product: Drugs Recipient: Estaderma South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
November 5, 2025

Maypharm – 718717 – 11/03/2025

Product: Drugs Recipient: Maypharm South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
November 5, 2025

Elle Pharm – 718713 – 11/03/2025

Product: Drugs Recipient: Elle Pharm United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 Elle Pharm: This […]
November 5, 2025

Cosmenic – 718621 – 11/03/2025

Product: Drugs Recipient: Cosmenic Panama Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, 2025 […]
November 5, 2025

Dermax Co., Ltd – 718712 – 11/03/2025

Product: Drugs Recipient: Dermax Co., Ltd China Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 Dermax Co., Ltd.: […]
November 5, 2025

AceCosm – 718610 – 11/03/2025

Product: Drugs Recipient: AceCosm Hong Kong SAR China Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 AceCosm: This […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0